The current COVID-19 pandemic caused by SARS-CoV-2 has emerged as a public health emergency. All nations are seriously challenged as the virus spreads rapidly across the globe with no regard for borders. The primary management of inflammatory bowel disease IBD involves treating uncontrolled inflammation with most patients requiring immune based therapies. However these therapies may weaken the immune system and potentially place IBD patients at increased risk of infections and infectious complications including those from COVID-19. Review Article: Prevention Diagnosis and Management of COVID-19 in the Inflammatory Bowel Disease Patient.